Phytochemicals in thyroid cancer: analysis of the preclinical studies

Purpose In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thyroid cancer cells. Results/Conclusions In particular, we describe their antiproliferative properties or ability to re-induce iodine retention, thus supporting their potential use as single agents or adjuvants in radioiodine-resistant thyroid cancer treatment.

Automated summary

Research on plant-derived compounds with anticancer activity against thyroid cancer cells shows their potential as single agents or adjuvants in treating radioiodine-resistant thyroid cancer, due to their antiproliferative properties and ability to re-induce iodine retention.